Nitazoxanide: a new broad spectrum antiparasitic agent (Q28287647)

Expert Review of Anti-infective Therapy

Europe PubMed Central

title

Nitazoxanide: a new broad spectrum antiparasitic agent (English)

0 references

author name string

Clinton A White

series ordinal

1

0 references

language of work or name

English

0 references

publication date

February 2004

0 references

published in

0 references

volume

2

0 references

issue

1

0 references

page(s)

43-9

0 references

cites work

The disappearing arsenal of antiparasitic drugs

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.43

Treatment of intestinal parasitic infections: a review of nitazoxanide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.43

Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.43

Efficacy of nitazoxanide, tizoxanide and tizoxanide glucuronide against Cryptosporidium parvum development in sporozoite-infected HCT-8 enterocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.43

Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.43

Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.43

Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.43

In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.43

In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.43

Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.43

Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.43

Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.43

Successful treatment with nitazoxanide of Enterocytozoon bieneusi microsporidiosis in a patient with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.43

Comparative clinical studies of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children from Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.43

In vitro parasiticidal effect of Nitazoxanide against Echinococcus multilocularis metacestodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.43

Successful treatment of human fascioliasis with nitazoxanide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.43

Imported Fasciola hepatica infection in the United States and treatment with triclabendazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.43

Nitazoxanide, a nitrothiazolide antiparasitic drug, is an anti-Helicobacter pylori agent with anti-vacuolating toxin activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.43

Opportunistic Parasitic Infections of the Intestinal Tract in the Era of Highly Active Antiretroviral Therapy: Is the CD4+Count So Important?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.43

Jejunal cytokine response in AIDS patients with chronic cryptosporidiosis and during immune reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.1.43